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Introduction 
Economic evaluations of new health technologies now typically produce an 
incremental cost per Quality Adjusted Life Year (QALY) value.  The QALY is a 
measure of health benefit that combines length of life with quality of life, 
where quality of life is assessed on a scale where zero represents a health 
state equivalent to being dead and one represents full health (Weinstein and 
Stason, 1977).  The challenge for decision makers, such as the Treasury, is to 
determine the appropriate size of the healthcare budget.  Bodies, such as the 
National Institute for Health and Clinical Excellent (NICE) in the U.K., must 
then determine how much it can afford to pay for a gain of one QALY, while 
operating under this fixed budget.  While there is no fixed cost-effectiveness 
threshold and each intervention is assessed on a case by case basis (Rawlins 
and Culyer, 2004), under normal circumstances the threshold will not be 
below £20,000 and not above £30,000 per QALY (NICE, 2008). 
 
Recent research has sought to determine the monetary value individuals place 
on a QALY to inform the size of the healthcare budget and the level of the 
cost-effectiveness threshold. This research has predominantly used 
Willingness to Pay (WTP) approaches (Johannesson and Meltzer 1998, Hirth et 
al. 2000, Abelson 2003, Johannesson and Johansson 1997, Johnson et al. 1998, 
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Gyrd-Hansen 2003).  However, WTP has a number of known problems, most 
notably its insensitivity to scope (Olsen et al. 2004).  In this paper we present 
an alternative approach to estimating the monetary value of a QALY (MVQ), 
which is based upon a Time Trade Off (TTO) exercise of income with health 
held constant at perfect health.  We present the methods and theory 
underlying this experimental approach and some results from an online 
feasibility study in the Netherlands.   
 
Background 
 
Willingness to Pay (WTP) has been used to estimate the MVQ in two ways.  
The first has been to elicit the WTP for a reduction in the risk of death and 
then calculate the value of a statistical life, from which the MVQ can be 
inferred.  Early studies using this approach produced WTP per QALY 
estimates ranging from £51,000 to £101,000 (in 2003 prices) (e.g. Johannesson 
and Meltzer 1998, Hirth et al. 2000, Abelson 2003).  More recently Mason et al. 
(2009) have used this method and produced estimates ranging from £24,219 
to £70,896.  The second approach has been to directly elicit a WTP value for 
changes in health status.  This can be through hypothetical generic quality of 
life improvements (Gyrd-Hansen 2003; Prades et al. 2009), hypothetical 
increases in life expectancy (Johannesson and Johansson 1997; Johnson et al. 
1998), improvements in own health amongst a patient population (King et al. 
2005) or alleviation of a specific health condition (Lundberg 1999).  Estimates 
from the direct approach are generally much lower than from the value of a 
statistical life approach.  However, the most recent study, by Prades et al. 
(2009), produced estimates ranging from €4,585 to €123,724. 
 
It has been shown that values elicited from WTP studies are influenced by 
factors of the study design, including: elicitation method (Frew et al. 2003), 
payment vehicle (Hayes et al. 1992) and the order of the questions if more 
than one programme/outcome is being valued (Stewart et al. 2002).  O’Brien 
and Gafni (1996) outline a conceptual framework for appropriate design 
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decisions in health care contingent valuation studies.  However, even if the 
WTP study is designed appropriately a number of other problems have been 
shown to be inherent in the WTP method.  These include insensitivity to scope 
(Olsen et al. 2004), strategic behaviour (Hackl and Pruckner, 2005), the 
restriction of personal income (O’Brien and Drummond, 1994) and protest 
responses (Dalmau-Matarrodona, 2001).  
 
Insensitivity to scope arises if respondents’ WTP does not change in response 
to the size of the outcome being valued.  Evidence of insensitivity to scope 
concerns economists because it contradicts the fundamental principles of 
neo-classical theory: since ‘more is better’ consumers should be prepared to 
sacrifice more money to achieve it (albeit at a diminishing rate).  From a 
practical perspective, if WTP results are to be used to inform the cost-
effectiveness threshold applied in health care allocation decisions it is crucial 
that two health gains of different sizes receive different values.  Olsen et al. 
(2004) asked respondents their WTP for either 100 or 50 patients, cancer 
radiotherapy for either 300 or 150 patients or a helicopter ambulance that 
would save either 10 or 15 lives. The results showed no significant differences 
in WTP for different sized health effects.  Chestnut et al. (1996) found that 
meanWTP to avoid four angina attacks did not differ significantly from mean 
WTP to avoid eight attacks.  A number of studies dealing with different sizes of 
risk reductions have also found evidence in support of scope insensitivity (see 
Smith and Desvouges 1987; Jones-Lee, Loomes and Phillips 1995).  However, 
Kartman et al. (1996a,b) and O’Conor et al. (1998) all found evidence against 
insensitivity to scope making it hard to draw definite conclusions. 
 
WTP is ultimately determined by ability to pay; in other words personal 
income acts as the budget constraint.  O’Brien and Drummond (1994) argued 
that WTP was only a valid method if we accept that the current distribution of 
income is appropriate.  Gold et al. (1996) describe WTP as ‘a measure that 
inherently favours the wealthy over the poor’ (p.28).  Distributional weights 
can be employed as a method to tackle inequities arising from the use of WTP 
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(see Donaldson 1999), but this still requires the assumption that individuals in 
the same income category have the same marginal utility of income.   
 
Strategic behaviour (free-riding) may occur in WTP studies in two directions.  
Firstly, if respondents think they will actually have to pay the amount they 
reveal they may underbid.  Alternatively, if respondents do not believe they will 
actually have to pay their stated WTP amount, but they want to influence the 
provision of the good in question, we might expect them to overbid.  In the 
environmental field Bohm (1984), Brubaker (1984) and Milon (1989) all found 
only minor strategic effects.  There is limited available evidence in the health 
care field.  Hackl and Pruckner (2005) test for free riding by asking Austrian 
respondents their WTP for the provision of health-related Red Cross services.  
They found only a few cases that would point towards free-riding behaviour.   
 
According to Dalmau-Matarrodona (2001) non-responses in WTP exercises fall 
into four categories: don’t know, real zeros, protest zeros and outliers.  He 
defines protest zeros as those coming from respondents who have negative 
attitudes towards the good in question and hence give a zero response, when 
their real value is positive.  The standard approach is to discard these 
observations.  However, this may cause problems through information loss 
and reduced sample size, and the results may be biased if the characteristics 
of those respondents giving protest responses differ from the rest of the 
sample.  Innovative methods to include protest responses have been 
experimented with (Dalmau-Matarrodona 2001 uses a double hurdle 
modelling approach) but protest responses remain a problem in WTP studies. 
 
Even if we overlook the above problems of the WTP technique, at a more 
conceptual level, a ‘social WTP value’ is necessary to aid policy makers set an 
appropriate cost effectiveness threshold.  Whether social WTP can be 
calculated as the average of individual WTP is far from clear.  Smith and 
Richardson (2005) point out that individual WTP is predicated on the notion 
that the payment made by each individual will reflect the benefit that they 
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receive from the good or service paid for.  However, under a publicly funded 
health scheme, the payment is largely unrelated to the benefits that the payee 
will obtain.  The relevant WTP question becomes how much the individual is 
prepared to pay for another’s health, with the caveat that they too can 
potentially benefit from the services that others receive.  Therefore, it is 
entirely possible for an individual’s personal WTP to diverge from their fair 
share of social WTP.     
 
Attempting to derive an MVQ has been termed as ‘building a bridge between 
CBA and CEA’ (Dolan and Edlin, 2002).  This is because if an MVQ is identified, 
then the costs of a treatment can be directly compared with the benefits, 
expressed in monetary net benefit terms and interpreted in standard welfare 
economic terms.  However, Dolan and Edlin (2002) have shown that some 
rather restrictive and unrealistic assumptions have to be made to build this 
bridge.  The approach of Johannesson and Meltzer (1998) requires that 
incomes be held constant across individuals for WTP to be proportional to the 
QALY gain.  Dolan and Edlin relax this assumption and show that health must 
be additively separable to consumption in the utility function, since the 
relationship between health and income would influence the ability of an 
individual to enjoy consumption.  Another attempt to link CBA and CEA, by 
Bleichrodt and Quiggin (1999), differs in that individual WTP figures are used, 
but this leads to differences in thresholds across individuals.  Ultimately, Dolan 
and Edlin argue that it is not possible to link CBA and CEA if: (i) the axioms of 
EU theory hold; (ii) the QALY model is valid in a welfare economic sense; and 
(iii) illness hinders the ability to enjoy consumption.   
 
The aim of this study is to offer an alternative approach to estimating an MVQ 
by identifying the level at which individual’s trade off between their own 
longevity and income. This approach may overcome some of the problems 
with WTP, such as insensitivity to scope, strategic behaviour and dependence 
upon ability to pay.  Below, the study design, results, and a discussion are 
presented. 
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Methods 
 
Data were gathered as part of a study seeking to determine whether 
respondents in TTO exercises consider the effects the states might have upon 
their income.  Data were gathered through an online self-complete 
questionnaire administered in the Netherlands.  Invitations were sent out to a 
subset of an existing panel of potential survey respondents in order to obtain a 
representative sample of 300 members of the Dutch general public.  We 
selected respondents between the ages of 18 and 65 as we felt that questions 
about income were most relevant for people in this age bracket.  The data 
collection was performed by an online market research company (Survey 
Sampling International; www.surveysampling.com).  Following a number of 
background, ranking and Visual Analogue Scale (VAS) questions respondents 
were presented with five different TTO exercises (see Tilling et al. 2009 for 
more details).   
 
Two of these TTO exercises were relevant for this study and all respondents 
answered both: 
 
TTO 1: Trading years to avoid an income loss in perfect health (equivalent 
loss)  
“You can live for 10 years in perfect health with (100 - Y)% of your current 
annual income for each year and then die or you can live for a shorter period 
of time in perfect health with your current annual income for each year and 
then die.” 
 
TTO 2: Trading years to achieve an income gain in perfect health 
(compensating gain) 
“You can live for 10 years in perfect health with your current annual income 
for each year and then die or you can live for a shorter period of time in 
perfect health with (100 + Y)% of your current annual income for each year 
and then die.” 
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Three income change levels (Y) were used: 20%, 40% and 60%, and 
respondents were randomised to one of these three income change levels 
which they then received in both TTO1 and TTO2.  Since the survey was 
administered in an online self-complete fashion there was no iterative 
process.  Respondents were simply asked to state how many years with higher 
income, was equivalent to 10 years with lower income.  It should also be noted 
that all respondents received the two questions in the same order: TTO1 
followed by TTO2.  Therefore, we cannot rule out the possibility that 
responses to TTO2 are affected by respondent’s having already seen TTO1. 
 
Essentially both questions can be interpreted as WTP questions.  However, 
while standard WTP questions ask people to trade money for an improvement 
in survival prospects, and thus by implication, length of life or health, these 
questions ask people to trade length of life for an improvement in income.  
Respondents are paying in years of life.  TTO 1 is a form of equivalent variation.  
Equivalent variation is ‘the amount of money a consumer would pay to avert a 
price increase’ (Hicks 1939).  In TTO1 the consumer is faced with a fall in 
income of X%, which is essentially the same as an increase in prices.  They are 
then asked how many years of life (rather than how much money) they would 
pay to avoid this ‘price increase’.  Similarly, TTO2 can be considered a form of 
compensating variation.  Compensating variation is ‘the amount of additional 
money a consumer requires to reach his initial level of utility after a change in 
prices’ (Hicks 1939).  For a drop in prices, the amount of additional money 
compensation will be negative.  TTO2 essentially corresponds to a 
compensating variation that identifies the number of years payable that would 
let the individual maintain the initial level of utility after a drop in prices, or 
increase in income. 
 
To see how the results from these questions can be used to derive an MVQ 
imagine that a respondent facing TTO 1 states that 9 years with normal annual 
income of €100,000 is equivalent to 10 years with 80% of this income, so 
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€80,000.  Therefore, using prospective lifetime income values and an additive 
utility function, this point of indifference gives us the following information: 
 
10U (Perfect Health) + €800,000 = 9U (Perfect Health) + €900,000  (1) 
10U (Perfect Health) – 9U (Perfect health) = €900,000 - €800,000  (2) 
U (Perfect Health) = €100,000      (3) 
 
This method requires that we assume additivity between health and income in 
the utility function.  In reality it is likely that the utility from a year in perfect 
health will be higher when combined with a higher amount of income.  
Therefore, we make the same assumption as Johannesson and Meltzer (1998), 
and hence do not avoid Dolan and Edlin’s (2002) impossibility theorem.  We 
also assume a constant marginal rate of substitution between health and 
income.  Relaxing this assumption would require us to estimate an 
indifference curve across a range of values.  Unfortunately we do not have 
enough data points for this to be possible in this study. 
 
The compensating gain data from TTO2 is analysed in a similar fashion to the 
equivalent loss data in TTO1.  Consider a respondent who is indifferent 
between 10 years with their current income and 9 years with 120% of their 
current income.  Their income is, once again, €100,000 per year: 
 
10 U(PH) + €1000,000 = 9 U(PH) + €1080,000    (4) 
10U (PH) – 9U (PH) = €1080,000 – €1000,000    (5) 
U(PH) = €80,000        (6) 
 
Notice that a compensating gain of €20,000 has led to a lower MVQ estimate 
than a gain of €20,000 in the equivalent loss question.  This is because, as a 
proportion, €20,000 is larger in the equivalent loss question. 
 
Predicting which of the two questions will give the higher estimates is not 
obvious.  As shown above, if an individual trades the same number of years in 
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each question the compensating gain question will give lower results.  
However, based on the assumption of diminishing marginal utility of income 
we would expect the compensating gain results to give a higher MVQ than the 
equivalent loss.  Respondents will trade fewer years in order to achieve an 
increase in income, hence each year is valued more highly in monetary terms. 
This is also supported by the findings of Kahneman and Tversky (1979): 
through a series of probabilistic choices they found risk aversion in choices 
involving sure gains, and risk seeking involving sure losses.  This suggests that 
respondents will trade more years in the equivalent loss questions than in the 
compensating gain questions, which would lead to higher MVQ values in the 
latter.   
 
Respondent Income 
 
In order to determine the level of “current annual income” for each 
respondent, respondents were asked to choose the income bracket within 
which their monthly income fell in the background characteristics questions.   
For our analysis these income brackets were converted into numerical values 
using the mid-point of each bracket (Layard et al. 2008).  For respondents in 
the lowest income bracket an income of two thirds of the upper limit of the 
bracket was used.  For respondents in the highest income bracket an income 
of 1.5 of the lower income limit of the bracket was assumed (Layard et al. 
2008).   
 
Non-Traders 
 
Given that the 3 TTO exercises that are not analysed in this paper involved 
four states each, there were a total of 14 TTO questions per respondent.  
Some respondents did not trade any time in any of the TTO exercises.  We 
have excluded these ‘extreme’ non-traders from our analysis.  However, some 
respondents may have traded in some of the TTO’s but not in the 
compensating gain and equivalent loss questions.  If we calculate an MVQ for 
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each individual and then aggregate (as outlined above), then these non-
traders cause a problem because the left hand side of equation (2) becomes 
0, meaning that the equation would give an indeterminate value.  There are 
two possible responses to this problem: the first (the “individual approach”) is 
to exclude all respondents that did not trade, and the second (the “aggregate 
approach”) is to aggregate at the start of the calculations i.e. use aggregate 
income and aggregate number of years traded.  We present results from both 
approaches.     
 
Negative Values 
 
One further problem is the generation of negative MVQ values.  For TTO1 if the 
percentage of life years the respondent is prepared to give up is larger than 
the percentage income loss he is faced with then his MVQ will be negative.  In 
other words if the respondent is faced with 20% income loss, and if they trade 
more than 2 years of life their MVQ value will be negative.  If they trade exactly 
2 years their MVQ value will be zero.  So for the 40% loss they can not trade 
more than 4 years, and for the 60% loss they cannot trade more than 6 years.  
For TTO2 the relationship is not linear.  For 20% gain they cannot trade more 
than 1.666 years, for 40% gain they can not trade more than 2.86 years and for 
60% gain they can not trade more than 3.75 years.  In the individual approach 
we truncate negative MVQ values at 0.  In the aggregate approach we leave the 
number of years traded unchanged.   
 
Results 
 
Data are available from 321 members of the Dutch general public.  After 
exclusion of 80 ‘extreme non-traders’ the sample size falls to 241.  Analysis 
performed in Tilling et al. (2009) shows that only 2 background variables were 
significantly correlated with being an extreme non-trader at the 1% 
significance level: respondents with children were more likely not to trade in 
any of the exercises, as were those who spontaneously included income in the 
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standard TTO question of hypothetical health states.  Extreme non-traders 
were in better health than traders, though this was only significant at the 10% 
level.   
 
Table 1 shows the background characteristics for the sample excluding 
extreme non-traders and then for each version (income change level) of the 
questionnaire.  The sample has slightly more males than females.  41.5% of the 
sample are not employed.  Just under half of the sample had children.  Less 
than half of the sample are married and the mean VAS score for own health 
was 0.75.  The results of the Chi2 tests show that the background 
characteristics do not differ significantly across the three versions of the 
questionnaire.  Only employment is weakly significantly different across the 
versions, with a smaller proportion of respondents in version 2 being in 
employment than in the other 2 versions. 
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Table 1 – Background characteristics by income change level 
 
    Full Sample 
Version 1 
(20% 
income 
change) 
Version 2 
(40% 
income 
change) 
Version 3 
(60% 
income 
change) 
Chi2 Test      
(p-values) 
Number of 
Respondents 
  241 78 80 83   
           
Gender Male  52.0% 50.0% 56.0% 49.5% 0.683 
  Famale 48.0% 50.0% 44.0% 50.5%   
Age Average (SD) 43.19 
(13.19) 
43.71 
(12.96) 
42.91 
(13.20) 
42.96 
(13.52) 0.808 
  18-35 32.0% 32.0% 31.0% 32.5%   
  36-50 31.5% 32.0% 28.0% 35.0%   
  51-65 36.5% 36.0% 41.0% 32.5%   
Educated beyond the 
minimum school 
leaving age 
Yes 66.0% 69.0% 64.0% 65.0% 0.750 
No 34.0% 31.0% 36.0% 35.0%   
Educated to Degree 
Level 
Yes 32.0% 37.0% 30.0% 29.0% 0.479 
No 68.0% 63.0% 70.0% 71.0%   
Employment Employed 53.5% 58.0% 45.0% 58.0% 0.098 
  Self-Employed 5.0% 4.0% 10.0% 1.0%   
  House Wife/Husband 12.5% 10.0% 17.5% 9.5%   
  Pensioner 7.0% 9.0% 4.0% 8.5%   
  Work Seeking 3.0% 5.0% 1.5% 2.5%   
  Unable to Work 10.0% 10.0% 11.0% 8.5%   
  Student 9.0% 4.0% 11.0% 12.0%   
Net Own Monthly 
Income 
<1000 Euros 38.0% 37.0% 46.0% 31.5% 0.237 
1000 - 1499 21.5% 18.0% 20.0% 26.5%   
  1500 - 1999 19.0% 20.5% 20.0% 15.5%   
  >2000 Euros 21.5% 24.5% 14.0% 26.5%   
Children Yes 49.5% 49.0% 52.5% 47.0% 0.773 
  No 50.5% 51.0% 47.5% 53.0%   
Religion Protestant 16.5% 14.0% 16.5% 19.0% 0.461 
  Roman Catholic 28.5% 33.5% 27.5% 25.5%   
  Atheist 49.5% 43.5% 51.0% 2.5%   
  Other 5.5% 9.0% 5.0% 53.0%   
Marital Status Married 42.5% 41.0% 47.5% 40.0% 0.561 
  Single/Never Married 22.5% 19.0% 19.0% 29.0%   
  Divorced 12.0% 10.5% 16.0% 9.5%   
  Widowed 2.0% 2.5% 25.0% 1.0%   
  Living Together 18.0% 24.5% 12.5% 17.0%   
  Other 3.0% 2.5% 2.5% 3.5%   
Mean Self-Reported 
Health on the EQ-VAS1    0.75 0.73 0.73 0.77 0.131 
 
 
 
                                                 
1 Due to the exclusion of some meaningless valuations, typically due to dead 
receiving a very high position on the VAS, the relevant sample sizes for this 
variable are: Full sample (213), Version1 (69), Version2 (69), Version3 (75).   
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Table 2 – Number of years traded both including and excluding non-traders 
 
 
        20% (n=78) 40% (n=80) 60% (n=83) 
        Loss  Gain Loss Gain Loss Gain 
Number of years traded to 
either avoid an income loss 
or achieve and an income 
gain including non-traders 
Mean 0.992 1.47 1.812** 1.33 2.451 1.511*** 
SD 2.23 2.96 2.74 2.63 3.28 2.89 
Median 0 0 0 0 1 0 
75th Percentile 0.25 1.42 4 1.08 4.5 1.75 
90th Percentile 4.92 5 5 5.5 8.92 5 
        
Loss 
(n=22) 
Gain 
(n=29) 
Loss 
(n=37) 
Gain 
(n=28) 
Loss 
(n=46) 
Gain 
(n=30) 
Number of years traded to 
either avoid an income loss 
or achieve and an income 
gain excluding non-traders 
Mean 3.5 3.95 3.91 3.81 4.43 4.17 
SD 2.99 3.74 2.83 3.24 3.27 3.47 
Median 2.25 2.5 4 2.96 3.75 2.75 
75th Percentile 5 5 5 6 6.42 7 
90th Percentile 9 10 9 10 9.92 9.96 
Numbers (1,2) represent points of comparison in t-tests.  Stars represent significance as follows: **5% level  ***1%level 
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Table 2 shows the mean number of years respondents were willing to trade, in 
both the compensating gain and equivalent loss questions, with and without 
respondents who did not trade any time.  Looking at the values for the larger 
sample, for two of the income change levels respondents are prepared to 
trade more years to avoid an income loss than they are to achieve an income 
gain.  However, these differences are only significant for the 60% income 
change level (tested through t-test and signalled by 1***, the number 
indicating the points of comparison and the *’s indicating the level of 
significance: * 10%, **5%, ***1%).  The median values are 0 in all but one case, 
which is a product of the large numbers of non-traders.  Mann-Whitney rank-
sum tests were performed comparing the values for the different income 
levels, both for equivalent loss and compensating gain values.  Comparison 
between 20% and 40% equivalent loss proved significant at the 10% level, 
while comparison between 20% and 60% equivalent loss proved significant at 
the 1% level.  For the equivalent loss questions the standard deviations 
generally increase as the level of loss increases, while no clear relationship can 
be observed for the gain questions.  The 75th and 90th percentiles show the 
skewness caused by the non-traders. 
 
For the smaller sample, without non-traders, the mean number of years 
traded is considerably higher across all questions.  More years are traded in 
the equivalent loss questions for the two more severe income change levels, 
but these differences are not significant.  None of the t-tests comparing values 
across the different income levels for both losses and gains are significant.   
 
Table 3 shows the MVQ estimates calculated at the individual level, without 
non-traders.  The mean MVQ values range from €17,438.74 to €65,956.57.  A 
larger proportion of respondents gave negative MVQ values (which were 
truncated to zero for the analysis) for the compensating gain questions than 
for the equivalent loss questions.  In general the mean MVQ values increase as 
the level of income change increases, 60% income gain being the only case 
where this does not hold.   The values are higher for the gain questions than 
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the loss questions, except in the case of the largest income change level.  The 
mean values are consistently higher than the median values which shows that 
the data are skewed.  In half of the cases the median is 0 which is caused by 
the large number of respondents who traded enough years to generate a 
negative MVQ value, which was then truncated to zero.  
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Table 3 – MVQ values calculated at the individual level (excluding non-traders) 
 
 
        Version 1: 20% Version 2: 40% Version 3: 60% 
  
 
    Loss Gain Loss Gain Loss Gain 
        (n=22) (n=29) (n=37) (n=28) (n=46) (n=30) 
Mean number of years traded   3.5 3.95 3.91 3.81 4.43 4.17 
Mean Annual Income (Euros)   15,041.50 16,375.45 14,833.95 15,675.43 21,041.22 18630.4 
Number of negative responses 
(truncated to zero)   11 17 16 14 13 14 
Income equivalent to 1 Quality 
Adjusted Life Year (Euros) 
Mean 17438.74 42212.17 43563.87 65956.57 56827.09 48845.79 
SD 44560.83 166649.90 138096.90 193760.10 126109.40 108569.70 
10th percentile 0.00 0.00 0.00 0.00 0.00 0.00 
25th percentile 0.00 0.00 0.00 0.00 0.00 0.00 
Median 0.00 0.00 0.00 1019.67 8672.73 10994.40 
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Table 4 – MVQ values calculated at the aggregate level with and without 
non-traders 
 
  Version 1: 20% Version2: 40% Version 3: 60% 
Excluding non-traders Loss Gain Loss Gain Loss Gain 
Number of Respondents 22 29 37 28 46 30 
Mean number of years traded 3.5 3.95 3.91 3.81 4.43 4.17 
Mean Annual Income (Euros) 15,041.50 16,375.45 14,833.95 15,675.43 21,041.22 18630.4 
Value of a QALY (Euros) -6446.36 -11359.17 341.45 -5488.46 7457.05 -2826.10 
Including non-traders Loss Gain Loss Gain Loss Gain 
Number of respondents 78 78 80 80 83 83 
Mean number of years traded 0.99 1.47 1.81 1.33 2.45 1.51 
Mean Annual Income (Euros) 17471.38 17471.38 15771.30 15771.30 20828.82 20828.82 
Value of a QALY (Euros) 17824.34 2804.93 19082.40 25352.66 30180.54 49437.41 
 
 
Table 4 shows the MVQ values calculated using aggregate values, first without 
the non-traders and then with the non-traders.  In all but two cases using the 
aggregate approach without the non-traders produces negative MVQ values.  
In the two cases where positive values are produced comparison with the 
results from the individual approach shows that the aggregate approach 
produces much lower estimates.  Considering the results from the aggregate 
approach, with non-traders, the estimates range from €2,804.93 to €49,437.41.  
These values are closer to those generated through the individual approach, 
especially for 20% loss and 60% gain which produce values very similar to the 
individual approach.  
 
Table 5 shows weighted mean QALY values for different income brackets for 
both the individual approach and the aggregate approach.  There are two 
negative values for the aggregate approach that are, once again, truncated to 
zero for the calculation of the weighted mean.  The results show no clear 
relationship between respondent income and mean QALY values.    For the 
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individual approach values are broadly similar across income levels suggesting 
MVQ values generated by our method are not a function of respondent 
income.   
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Table 5 – Weighted mean QALY values for different income brackets for both the individual approach and the aggregate 
approach 
 
 
`   Version1: 20% Version 2: 40% Version 3: 60%   
  Income Level  Loss n Gain n Loss n Gain n Loss n Gain n 
Weighted Mean 
QALY value 
        
 
      
 
  
 
  
 
    
Individual 
Approach 
Less than 12,000 euros 22,522.93 11 19,941.96 14 13,235.43 18 48,448.81 11 117,113.60 13 68,606.70 11 45,836.73 
12,000 to 17,999 euros 22,800.02 5 11,294.11 4 104,285.80 7 36,571.42 7 17,863.63 11 35,999.99 4 39,096.76 
18,000 to 23,999 euros 0.00 2 0.00 5 82,579.01 7 149,400.10 7 56,405.78 9 36,120.00 5 66,060.17 
>24,000 euros 5,475.00 4 149,964.90 6 13,114.29 5 4,015.39 3 29,801.30 13 38,609.99 10 43,239.61 
      22   29   37   28   46   30   
        
 
      
 
  
 
  
 
    
Aggregate 
Approach 
Less than 12,000 euros 5576.76 29 0.00 29 7421.69 37 16976.84 37 19661.98 26 13007.31 26 10,401.49 
12,000 to 17,999 euros 15000.00 14 24372.88 14 23535.65 16 28220.67 16 22190.08 22 112570.56 22 41,769.77 
18,000 to 23,999 euros 40046.51 16 0.00 16 40810.15 16 16932.05 16 22674.18 13 71487.57 13 30,985.80 
>24,000 euros 34747.61 19 8999.70 19 33449.06 11 40953.74 11 29389.61 22 38094.48 22 30,137.31 
      78   78   80   80   83   83   
 
Measuring the value of life 
 - 22 - 
Discussion and Conclusion 
 
The aim of this study was not to present a definitive MVQ for the Netherlands, 
but to test the feasibility of an alternative method of eliciting an MVQ.  The 
results from this small-scale online study suggest that the compensating gain 
and equivalent loss TTO exercises have potential, but a number of problems 
must be overcome before it can challenge WTP as the dominant method of 
estimating an MVQ.  Generally respondents in our new method give up more 
years when faced with a larger income change level, thus suggesting some 
sensitivity to scope.  However, these differences are not always significant and 
are never significant without the ‘non traders’.  Studies with larger sample 
sizes may be able to determine whether the method is sensitive to scope.   
 
We feel our method entails a greater sense of trade-off than WTP, since 
respondents are forced to consider giving up years of life from a finite 10 year 
survival, rather stating an open ended amount of money they would pay.  
Furthermore, the method makes strategic behaviour difficult as it is not 
obvious to the respondent how the results from the exercise will be used, but 
the results from this feasibility study do not allow us to specifically test this.  
However, while the ‘abstract’ nature of the exercise may reduce strategic 
behaviour it may also be a disadvantage, as suggested by the high propensity 
of non-responses.  We feel that this is an artefact of using an online survey, 
rather than a protest against these particular questions. Van Nooten et al. (in 
press) also found numerous respondents opted not to trade in the TTO 
exercises in their online questionnaire. This argument is supported by the fact 
that in the whole study (Tilling et al. 2009) 80 of 321 respondents did not trade 
in any of the 14 TTO exercises.  We suspect many of these respondents chose 
not to trade for time saving purposes.  Rather than take the time to think out a 
meaningful response, ‘non-traders’ may have entered ‘10 years’ in each 
question to speed up the process.  The sooner they complete the exercise the 
sooner they are awarded a given amount of money to be donated to a charity 
of their choice and the chance to win a prize themselves.  Therefore, if this 
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approach is to be tested further, it would be most appropriate to use an 
interview method of elicitation.  However, we cannot rule out the possibility 
that these responses are either meaningful responses or protest responses.  If 
they are meaningful responses they would highlight a problem with the 
method – those who do not trade any time cannot be included in the analysis.  
If they are protest responses they would suggest our method is unlikely to 
overcome this particular weakness of WTP.   
 
A serious problem with the TTO based approach is the elicitation of negative 
MVQ values.  Referring to Equation 7, given the assumption of additivity, a 
rational respondent should not trade more than two years (i.e. a value of eight 
on the right hand side of the equation) because to do so would mean a lower 
total lifetime income.  However, in reality it is plausible that individuals may 
wish to live for a shorter period of time with high income than for a longer 
period of time with lower income, even though their total lifetime income may 
be lower.  It is also likely that respondents may not have been able to 
determine the point at which their lifetime income became lower.  If these 
questions were tested through an interview elicitation procedure it may be 
possible to use a visual aid that would attempt to make it clearer to 
respondents the point at which lifetime income in the trading scenario 
becomes lower than lifetime income in the alternative scenario.  This could be 
done by adapting the standard MVH TTO board to include an additional strip 
for lifetime income.  This may reduce the number of respondents trading too 
many years.   
 
In this study respondents were told to imagine perfect health in both 
scenarios. In future work it may be preferable to tell respondents they would 
be in their own current state of health.  Their current health could then be 
valued through either conventional TTO or VAS and the values obtained could 
be divided by the value of their current health to give MVQ values.  This may 
reduce the number of hypothetical aspects and hence make the task more 
manageable for respondents who are currently not in full health.  However, 
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this approach would entail further dependence upon the assumption of no 
interactions between health and income.  This assumption, one of the 
impossibility theorem criteria set out by Dolan and Edlin (2002) is not avoided 
in this study.  The MVQ value elicited is essentially determined by the choice of 
income change level.  A large scale study would make it possible to gain values 
for enough income change levels to estimate an indifference curve between 
health and income.  An average MVQ value across a range of income change 
levels could then be estimated.   
 
It is not clear whether the ‘individual’ approach or the ‘aggregate’ approach is 
preferable.  The use of the aggregate approach without non-traders does not 
appear to be a credible option due to the generation of negative values.  
However, the validity of results using the aggregate approach with non-traders 
is questionable as these valuations may be meaningless strategic non-trades.  
On the other hand, the individual approach has the drawback of small sample 
sizes.  Before a preference can be formed more research using face to face 
interviews is needed to try and determine whether the non-trades are 
strategic or true indicators of preference, and hence whether the calculation 
method needs to be able to accommodate them.  Regardless of which method 
is used if the results are to be generalised to infer an MVQ it is crucial that the 
income of the sample is representative of society.  Even if this method can be 
refined to estimate a reliable MVQ this does not overcome the problems of 
inferring a social value of a QALY from this information.   
 
In summary, an alternative method for the elicitation of MVQ based on the 
TTO has been developed and found to be feasible for respondents to answer.  
A number of problems were encountered, most notably the elicitation of ‘non 
trades’, and negative values.  An interview based study that requires 
respondents to engage in an iterative process, and that can be supplemented 
by a visual aid, is required to determine whether this approach is valid and 
should be taken forward as an alternative to WTP. 
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